Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   creutzfeldt jakob disease
  

Disease ID 286
Disease creutzfeldt jakob disease
Definition
A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
Synonym
cjd
cjd (creutzfeldt jakob disease)
cjd (creutzfeldt-jakob disease)
cjd - creutzfeldt-jakob disease
cjd creutzfeldt jakob dis
classic creutzfeldt-jakob disease
creutzfeld-jakob disease
creutzfeldt jacob disease
creutzfeldt jakob dis
creutzfeldt jakob syndrome
creutzfeldt-jacob disease
creutzfeldt-jakob disease
creutzfeldt-jakob disease (disorder)
creutzfeldt-jakob syndrome
creutzfeldt-jakob syndrome [disease/finding]
creutzfeldt-jakob's disease
disease, creutzfeldt jacob
disease, creutzfeldt-jakob
disease, jakob-creutzfeldt
encephalopathies, subacute spongiform
encephalopathy, subacute spongiform
jacob disease, creutzfeldt
jakob creutzfeldt dis
jakob creutzfeldt disease
jakob creutzfeldt syndrome
jakob-creutzfeld disease
jakob-creutzfeldt disease
jakob-creutzfeldt disease (disorder)
jakob-creutzfeldt disease, unspecified
jakob-creutzfeldt syndrome
jcd - jakob-creutzfeldt disease
spongiform enceph subacute
spongiform encephalopathies, subacute
spongiform encephalopathy subacute
spongiform encephalopathy, subacute
subacute spongiform encephalopathies
subacute spongiform encephalopathy
syndrome, creutzfeldt-jakob
syndrome, jakob-creutzfeldt
transmissible virus dementia
transmissible virus dementia (disorder)
Orphanet
OMIM
DOID
UMLS
C0022336
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:15)
C0497327  |  dementia  |  5
C0743039  |  progressive dementia  |  4
C0038220  |  status epilepticus  |  3
C0162534  |  spongiform encephalopathy  |  3
C0524851  |  neurodegenerative disease  |  2
C0524851  |  neurodegenerative diseases  |  2
C0031069  |  familial mediterranean fever  |  1
C0002395  |  alzheimer's disease  |  1
C0851578  |  sleep disorders  |  1
C1527336  |  sjogren syndrome  |  1
C0043046  |  wasting disease  |  1
C0011570  |  depression  |  1
C0027765  |  neurological disease  |  1
C1135993  |  chronic wasting disease  |  1
C0752347  |  dementia with lewy bodies  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:14)
216  |  ALDH1A1  |  CTD_human
3119  |  HLA-DQB1  |  CTD_human
5621  |  PRNP  |  CLINVAR;CTD_human;GWASCAT;UNIPROT;ORPHANET
780851  |  SNORD3A  |  CTD_human
3822  |  KLRC2  |  CTD_human
8360  |  HIST1H4D  |  CTD_human
7280  |  TUBB2A  |  CTD_human
22926  |  ATF6  |  CTD_human
79644  |  SRD5A3  |  CTD_human
151507  |  MSL3P1  |  CTD_human
79974  |  CPED1  |  CTD_human
319101  |  KRT73  |  CTD_human
9108  |  MTMR7  |  GWASCAT
692157  |  SNORA16B  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:25)
5621  |  PRNP  |  CIPHER;CTD_human
23627  |  PRND  |  CIPHER
102  |  ADAM10  |  CIPHER
348  |  APOE  |  CIPHER
149830  |  PRNT  |  CIPHER
11075  |  STMN2  |  CIPHER
1509  |  CTSD  |  CIPHER
3574  |  IL7  |  CIPHER
9108  |  MTMR7  |  CIPHER
79031  |  PDCL3  |  CIPHER
63876  |  PKNOX2  |  CIPHER
7103  |  TSPAN8  |  CIPHER
4137  |  MAPT  |  CIPHER
780851  |  SNORD3A  |  CTD_human
3822  |  KLRC2  |  CTD_human
8360  |  HIST1H4D  |  CTD_human
79644  |  SRD5A3  |  CTD_human
7280  |  TUBB2A  |  CTD_human
151507  |  MSL3P1  |  CTD_human
79974  |  CPED1  |  CTD_human
216  |  ALDH1A1  |  CTD_human
319101  |  KRT73  |  CTD_human
692157  |  SNORA16B  |  CTD_human
3119  |  HLA-DQB1  |  CTD_human
22926  |  ATF6  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:27)
160  |  AP2A1  |  2.416  |  DISEASES
203228  |  C9orf72  |  1.005  |  DISEASES
23066  |  CAND2  |  2.258  |  DISEASES
100506742  |  CASP12  |  1.305  |  DISEASES
875  |  CBS  |  1.261  |  DISEASES
1270  |  CNTF  |  1.249  |  DISEASES
9244  |  CRLF1  |  1.719  |  DISEASES
29103  |  DNAJC15  |  3.038  |  DISEASES
80331  |  DNAJC5  |  2.397  |  DISEASES
2258  |  FGF13  |  1.054  |  DISEASES
2534  |  FYN  |  1.153  |  DISEASES
9446  |  GSTO1  |  1.648  |  DISEASES
3005  |  H1F0  |  1.392  |  DISEASES
23764  |  MAFF  |  2.821  |  DISEASES
4137  |  MAPT  |  2.435  |  DISEASES
4477  |  MSMB  |  3.261  |  DISEASES
8856  |  NR1I2  |  1.043  |  DISEASES
11315  |  PARK7  |  1.073  |  DISEASES
5294  |  PIK3CG  |  1.429  |  DISEASES
10687  |  PNMA2  |  4.151  |  DISEASES
5621  |  PRNP  |  6.482  |  DISEASES
149830  |  PRNT  |  2.973  |  DISEASES
5649  |  RELN  |  1.505  |  DISEASES
399  |  RHOH  |  2.496  |  DISEASES
6623  |  SNCG  |  1.785  |  DISEASES
503542  |  SPRN  |  2.376  |  DISEASES
7018  |  TF  |  1.31  |  DISEASES
Locus(Waiting for update.)
Disease ID 286
Disease creutzfeldt jakob disease
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:19)
HP:0000605  |  Supranuclear gaze paralysis
HP:0000505  |  Poor vision
HP:0007076  |  Extrapyramidal muscular rigidity
HP:0000738  |  Sensory hallucination
HP:0001289  |  Confusion
HP:0000741  |  Apathy
HP:0000746  |  Delusions
HP:0002922  |  Increased CSF protein
HP:0000716  |  Depression
HP:0001269  |  Hemiparesis
HP:0002066  |  Gait ataxia
HP:0000737  |  Irritability
HP:0000726  |  Dementia
HP:0005327  |  Loss of facial expression
HP:0002381  |  Aphasia
HP:0002354  |  Memory loss
HP:0000739  |  Anxiety
HP:0000751  |  Personality changes
HP:0001336  |  Myoclonic jerks
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:15)
HP:0000726  |  Dementia  |  7
HP:0100315  |  Lewy bodies  |  4
HP:0002133  |  Status epilepticus  |  3
HP:0001298  |  Encephalopathy  |  3
HP:0001268  |  Mental deterioration  |  2
HP:0001336  |  Myoclonic jerks  |  2
HP:0003470  |  Inability to move  |  1
HP:0100022  |  Movement disorder  |  1
HP:0001250  |  Seizures  |  1
HP:0002367  |  Visual hallucinations  |  1
HP:0000738  |  Sensory hallucination  |  1
HP:0002446  |  Astrocytosis  |  1
HP:0000716  |  Depression  |  1
HP:0001297  |  Cerebral vascular events  |  1
HP:0001269  |  Hemiparesis  |  1
Disease ID 286
Disease creutzfeldt jakob disease
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:5)
C0751523  |  nonconvulsive status epilepticus  |  3
C0497327  |  dementia  |  3
C0021311  |  infections  |  2
C0018989  |  hemiparesis  |  1
C0027066  |  myoclonus  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:75)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs122733502213733063876PKNOX2umls:C0022336GAD[Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.]0.0023670322012PKNOX211125371150GA
rs140842009183257855621PRNPumls:C0022336BeFreePoint mutations M232R (PrP(232R)), M232T (PrP(232T)), and P238S (PrP(238S)) in the glycosylphosphatidylinositol signal peptide (GPI-SP) of the prion protein (PrP(C)) segregate with familial Creutzfeldt-Jakob disease (CJD).0.8586754892008GPI1934378959CT
rs1460163190815153574IL7umls:C0022336GAD[The polymorphic codon 129 of PRNP was the main genetic risk factor for vCJD; however, additional candidate loci have been identified, which justifies functional analyses of these biological pathways in prion disease.]0.0023670322009NA879315213GA
rs14601631908151511075STMN2umls:C0022336GAD[Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.]0.0026384742009NA879315213GA
rs1495377221373307103TSPAN8umls:C0022336GAD[Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.]0.0023670322012NA1271183321GC
rs17571184265791509CTSDumls:C0022336GAD[This mutation event has been observed to alter the protease activity of the cathepsin D protein and has been linked to an increase in amyloid beta plaque formation in AD.]0.010368332008CTSD111761364GA
rs1799990190815155621PRNPumls:C0022336GWASCATA similar association was found in a small sample of patients with iatrogenic CJD (p=0.030) but not in patients with sporadic CJD (sCJD) or kuru.0.8586754892009PRNP204699605AG
rs179999086478795621PRNPumls:C0022336BeFreeFFI and a familial type of Creutzfeldt-Jakob disease (CJD178), share the D178N mutation in the PrP gene but have distinct phenotypes linked to codon 129, the site of a methionine/valine polymorphism (129M/V).0.8586754891996PRNP204699605AG
rs1799990128156035621PRNPumls:C0022336BeFreeA total of 616 chromosomes from control individuals of all major continental groups, and six individuals affected by either Creutzfeldt-Jakob disease (CJD) or fatal familial insomnia (FFI), were typed with a new single-reaction protocol method and were also sequenced, with total reproducibility to screen variation at important positions (385A>G: M129V and 655G>A: E219K) in the human prion protein gene (PRNP).0.8586754892003PRNP204699605AG
rs1799990190815155621PRNPumls:C0022336GAD[A similar association was found in a small sample of patients with iatrogenic CJD (p=0.030) but not in patients with sporadic CJD (sCJD) or kuru.]0.8586754892009PRNP204699605AG
rs1799990216000435621PRNPumls:C0022336BeFreeAn important determinant for CJD risk and phenotype is the M129V polymorphism of the human prion protein gene (PRNP), but there are also other coding and non-coding polymorphisms inside this gene.0.8586754892011PRNP204699605AG
rs1799990172028495621PRNPumls:C0022336BeFreeThe polymorphism at codon 129 (M129V) of the human prion protein gene (PRNP) is a known risk factor for Creutzfeldt-Jakob disease (CJD) in Caucasians.0.8586754892006PRNP204699605AG
rs1799990118402015621PRNPumls:C0022336BeFreeDistribution of the M129V polymorphism of the prion protein gene in a Turkish population suggests a high risk for Creutzfeldt-Jakob disease.0.8586754892001PRNP204699605AG
rs1799990168976055621PRNPumls:C0022336BeFreePrion protein gene polymorphism M129V represents a known risk factor for Creutzfeldt-Jakob disease.0.8586754892006PRNP204699605AG
rs1799990163240955621PRNPumls:C0022336BeFreeThe polymorphism at codon 129 (M129V) of the prion protein gene (PRNP) is a recognized genetic marker for susceptibility to Creutzfeldt-Jakob disease (CJD) in the Caucasians.0.8586754892005PRNP204699605AG
rs1799990NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699605AG
rs1799990182360055621PRNPumls:C0022336BeFreeOur proband was MM homozygous for the M129V polymorphism within the prion protein gene (PRNP), a known risk factor for CJD.0.8586754892008PRNP204699605AG
rs1800014128156035621PRNPumls:C0022336BeFreeA total of 616 chromosomes from control individuals of all major continental groups, and six individuals affected by either Creutzfeldt-Jakob disease (CJD) or fatal familial insomnia (FFI), were typed with a new single-reaction protocol method and were also sequenced, with total reproducibility to screen variation at important positions (385A>G: M129V and 655G>A: E219K) in the human prion protein gene (PRNP).0.8586754892003PRNP204699875GA
rs193922906NA5621PRNPumls:C0022336CLINVARNA0.858675489NANANANANANA
rs28933385252799815621PRNPumls:C0022336BeFreeThree independent reports have claimed anticipation in Creutzfeldt-Jakob disease (CJD) caused by the c.598G > A mutation in PRNP encoding a p.Glu200Lys (E200K) substitution in the prion protein.0.8586754892014PRNP204699818GA
rs28933385205931905621PRNPumls:C0022336BeFreeThe E200K mutation is the most frequent prion protein gene (PRNP) mutation detected worldwide that is associated with Creutzfeldt-Jakob disease (CJD) and thought to have overlapping features with sporadic CJD, yet detailed neuropathological studies have not been reported.0.8586754892011PRNP204699818GA
rs28933385205291155621PRNPumls:C0022336BeFreeCodon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease.0.8586754892010PRNP204699818GA
rs28933385223181255621PRNPumls:C0022336BeFreeRecently, we reported widespread intraneuronal prion protein (PrP) immunoreactivity in genetic Creutzfeldt-Jakob disease (CJD) associated with the E200K mutation.0.8586754892012PRNP204699818GA
rs28933385106655015621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation.0.8586754892000PRNP204699818GA
rs28933385105228925621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease (CJD) linked to the E200K mutation of the prion protein (PrP) gene presents within a wide range of phenotypic heterogeneity, including the age at disease onset.0.8586754891999PRNP204699818GA
rs28933385235652365621PRNPumls:C0022336BeFreeAge at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene.0.8586754892013PRNP204699818GA
rs28933385112594835621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease (CJD) in Libyan Jews, linked to the E200K mutation in PRNP (E200KCJD), is the most prevalent of the inherited prion diseases.0.8586754892001PRNP204699818GA
rs28933385195977635621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease with E200K PRNP mutation: a case report and revision of the literature.0.8586754892009PRNP204699818GA
rs28933385NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699818GA
rs28933385121976325621PRNPumls:C0022336BeFreeIn the Slovak CJD group 95 out of 136 CJD cases (74.2%) carried a CJD-specific mutation in the prion protein gene (PRNP) at codon 200 (mutation E200K).0.8586754892002PRNP204699818GA
rs28933385232961375621PRNPumls:C0022336BeFreeMolecular analysis confirmed genetic CJD (PRNP E200K mutation).0.8586754892013PRNP204699818GA
rs28933385215088345621PRNPumls:C0022336BeFreeThe purpose of this study was (1) to detect asymptomatic carriers of the prion protein gene mutation E200K, which is associated with Creutzfeldt-Jakob disease (CJD), in corneal donors and in the general population of Slovakia and (2) to assess the genetic testing of corneal donors as an effective preventive measure against iatrogenic infection in a country with an unusually high incidence of genetic CJD.0.8586754892011PRNP204699818GA
rs28933385103607785621PRNPumls:C0022336BeFreeA novel phenotype of familial Creutzfeldt-Jakob disease (CJD) with mutated codon 200 of the prion protein gene (PRNP) coupled with the valine codon 129 (E200K-129V haplotype) has two features never observed in subjects carrying the pathogenic mutation coupled with the methionine codon 129 (E200K-129M haplotype): (1) plaque-like prion protein (PrP) deposits in the cerebellum and (2) type 2 protease-resistant prion protein (PrP(res)).0.8586754891999PRNP204699818GA
rs28933385126774445621PRNPumls:C0022336BeFreeDistinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease.0.8586754892003PRNP204699818GA
rs28933385205149925621PRNPumls:C0022336BeFreeThe first Chinese case of Creutzfeldt-Jakob disease with mutation of E200K in PRNP.0.8586754892010PRNP204699818GA
rs2893338585291275621PRNPumls:C0022336BeFreeComplete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene.0.8586754891995PRNP204699818GA
rs28933385207304665621PRNPumls:C0022336BeFreeAn atypical phenotype of CJD associated with the E200K mutation in the prion protein gene.0.8586754892010PRNP204699818GA
rs28933385220262935621PRNPumls:C0022336BeFreeSlovakia is characterised by an unusually high number of patients affected by genetic Creutzfeldt-Jakob disease (CJD) with E200K mutation at the PRNP gene.0.8586754892011PRNP204699818GA
rs29530122210626253461ZBTB38umls:C0022336BeFreeSNPs at the ZBTB38-RASA2 locus were associated with CJD in the UK (rs295301, P = 3.13 × 10(-8); OR, 0.70) but these SNPs showed no replication evidence of association in German sCJD or in Papua New Guinea-based tests.0.0002714422012NA3141619799GA
rs295301222106265922RASA2umls:C0022336BeFreeSNPs at the ZBTB38-RASA2 locus were associated with CJD in the UK (rs295301, P = 3.13 × 10(-8); OR, 0.70) but these SNPs showed no replication evidence of association in German sCJD or in Papua New Guinea-based tests.0.0002714422012NA3141619799GA
rs398122370107902165621PRNPumls:C0022336BeFreeIdentification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.0.8586754892000PRNP204699851GC
rs398122370NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699851GC
rs4921542221373309108MTMR7umls:C0022336GAD[Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.]0.1226384742012MTMR7;LOC102724838817348068TG
rs4921542221373309108MTMR7umls:C0022336GWASCATGenome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.0.1226384742012MTMR7;LOC102724838817348068TG
rs6107516221373305621PRNPumls:C0022336GWASCATPost hoc analysis to assess our main results included 5711 French controls, 445 Dutch controls, and 446 sporadic Creutzfeldt-Jakob disease (CJD) cases.0.8586754892012PRNP204696446GA
rs74315401165976505621PRNPumls:C0022336BeFreeA proline-to-leucine substitution at prion protein (PrP) residue 102 (P102L), classically associated with the Gerstmann-Sträussler-Scheinker (GSS) phenotype, also shows marked clinical and pathological heterogeneity, including patients with a Creutzfeldt-Jakob disease (CJD) phenotype.0.8586754892006PRNP204699525CT
rs7431540185207195621PRNPumls:C0022336BeFreeIn contrast, a recent case with proven P102L mutation of the PRNP gene had rapidly developing dementia and severe cortical damage indistinguishable from the clinicopathological phenotype of Creutzfeldt-Jakob disease (CJD).0.8586754891995PRNP204699525CT
rs74315402196752405621PRNPumls:C0022336BeFreeThe biophysical properties of PrP from Tg(A116V) mice and human GSS(A117V) revealed a similarly low fraction of insoluble PrP and a weakly protease-resistant approximately 13 kDa midspan PrP fragment, not observed in CJD.0.8586754892009PRNP204699570CT
rs74315403NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699752GA
rs74315403241185455621PRNPumls:C0022336BeFreePanencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene.0.8586754892013PRNP204699752GA
rs74315403210719445621PRNPumls:C0022336BeFreeFatal familial insomnia (FFI) and genetic Creutzfeldt-Jakob disease (CJD(D178N,)(129V)) are two phenotypes that share a common point mutation at codon 178 of the prion protein gene (PRNP), but differ in their polymorphism at codon 129 of the mutant allele.0.8586754892010PRNP204699752GA
rs7431540392887285621PRNPumls:C0022336BeFreeWe investigated the allelic origin of PrP(res) in brains of subjects heterozygous for the D178N mutation linked to fatal familial insomnia (FFI) and a subtype of Creutzfeldt-Jakob disease (CJD178), as well as for insertional mutations associated with another CJD subtype.0.8586754891997PRNP204699752GA
rs7431540386478795621PRNPumls:C0022336BeFreeFFI and a familial type of Creutzfeldt-Jakob disease (CJD178), share the D178N mutation in the PrP gene but have distinct phenotypes linked to codon 129, the site of a methionine/valine polymorphism (129M/V).0.8586754891996PRNP204699752GA
rs74315403128492385621PRNPumls:C0022336BeFreeAccumulation of an isoform of protease-resistant PrP fragment in FFI distinct from that found in a familial form of Creutzfeldt-Jakob disease with the same D178N mutation, shows the effect of the polymorphism at codon 129 of PRNP on phenotypic expression and the possibility of distinct prion strains with diverse pathological potential.0.8586754892003PRNP204699752GA
rs7431540395314355621PRNPumls:C0022336BeFreeThe D178N mutation, known to be linked to 2 different phenotypes: Fatal Familial Insomnia (FFI) and CJD, was not described so far among Jews.0.8586754891998PRNP204699752GA
rs74315407105261985621PRNPumls:C0022336BeFreeMutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease.0.8586754891999PRNP204699848GA
rs74315407NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699848GA
rs74315407254503915621PRNPumls:C0022336BeFreeDifferent mechanisms can be hypothesized to explain the pathogenic role of mutant residues: V210I and R208H substitutions can increase the concentration of PrP(C) and the probability to form insoluble aggregates, or they may facilitate the formation of pathological intermediates, or, alternatively, they may increase the affinity for ligands that are involved in the initial phases of PrP(CJD) formation and aggregation.0.8586754892014PRNP204699848GA
rs74315408212693315621PRNPumls:C0022336BeFreeAn autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type.0.8586754892011PRNP204699758GA
rs74315408197032645621PRNPumls:C0022336BeFreeAn autopsy case of Creutzfeldt-Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology.0.8586754892010PRNP204699758GA
rs74315408254826005621PRNPumls:C0022336BeFreeRare V180I mutation in PRNP gene of a Chinese patient with Creutzfeldt-Jakob disease.0.8586754892015PRNP204699758GA
rs74315408200516875621PRNPumls:C0022336BeFreeThe present study reported DWI results in cases of familial CJD with a V180I mutation (CJD180) in the prion protein gene as well as neurological findings.0.8586754892009PRNP204699758GA
rs74315408NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699758GA
rs74315409NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699915TG
rs74315409194225375621PRNPumls:C0022336BeFreePatients with genetic Creutzfeldt-Jakob disease in which arginine is substituted for methionine at codon 232 (M232R) of the prion protein gene (CJD232) have been described in Japan, and a recent study has revealed the presence of two clinical phenotypes: a rapidly progressive type (rapid-type) and a slowly progressive type (slow-type).0.8586754892009PRNP204699915TG
rs74315409219832615621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease with the M232R mutation in the prion protein gene in two cases showing different disease courses: a clinicopathological study.0.8586754892012PRNP204699915TG
rs74315409179659615621PRNPumls:C0022336BeFreeTo describe the clinical features of Creutzfeldt-Jakob disease with a substitution of arginine for methionine (M232R substitution) at codon 232 (CJD232) of the prion protein gene (PRNP).0.8586754892007PRNP204699915TG
rs74315409183257855621PRNPumls:C0022336BeFreePoint mutations M232R (PrP(232R)), M232T (PrP(232T)), and P238S (PrP(238S)) in the glycosylphosphatidylinositol signal peptide (GPI-SP) of the prion protein (PrP(C)) segregate with familial Creutzfeldt-Jakob disease (CJD).0.8586754892008PRNP204699915TG
rs74315412NA5621PRNPumls:C0022336CLINVARNA0.858675489NAPRNP204699843GA
rs74315412157534355621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene.0.8586754892005PRNP204699843GA
rs74315412157391005621PRNPumls:C0022336BeFreeCreutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment.0.8586754892005PRNP204699843GA
rs74315412217919755621PRNPumls:C0022336BeFreeThe first Chinese case of Creutzfeldt-Jakob disease patient with R208H mutation in PRNP.0.8586754892011PRNP204699843GA
rs74315412254503915621PRNPumls:C0022336BeFreeDifferent mechanisms can be hypothesized to explain the pathogenic role of mutant residues: V210I and R208H substitutions can increase the concentration of PrP(C) and the probability to form insoluble aggregates, or they may facilitate the formation of pathological intermediates, or, alternatively, they may increase the affinity for ligands that are involved in the initial phases of PrP(CJD) formation and aggregation.0.8586754892014PRNP204699843GA
rs75659812213733079031PDCL3umls:C0022336GAD[Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.]0.0023670322012NA2100807869GA
rs759326282516004254209TREM2umls:C0022336BeFreeWe used next generation sequencing of the whole gene (n = 700), exon 2 Sanger sequencing (n = 2634), p.R47H genotyping (n = 3518), and genome wide association study imputation (n = 13,048) to determine whether TREM2 variants are risk factors or phenotypic modifiers in patients with AD (n = 1002), frontotemporal dementia (n = 358), sporadic (n = 2500), and variant (n = 115) Creutzfeldt-Jakob disease (CJD).0.0002714422014TREM2;LOC105375056641161514CA,T
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:43)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
121742737rs10916983TCrs10916983221373309.15E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tNANA
1162905434rs6681091TGrs6681091221373302.40E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
1204367668rs3014622GCrs3014622221373301.09E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tCNA
1240919970rs16848948TCrs16848948221373305.41E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
1240963070rs16840647AGrs16840647221373304.02E-07NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tARGS7
2101424331rs7565981GArs7565981221373304.00E-08NA2.98[2.03-4.35] 93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGNA
2101958295rs4851422GArs4851422221373303.13E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
4114085448rs407709ATrs407709221373303.94E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tAANK2
4188030901rs1487590GArs1487590221373304.79E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGNA
541504813rs662066AGrs662066221373309.28E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tAPLCXD3
541505689rs676328TCrs676328221373305.73E-07NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tCPLCXD3
541506860rs3863150TCrs3863150221373305.73E-07NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tAPLCXD3
5140855329rs4151701GArs4151701221373303.45E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGPCDHGB4
66909328rs9392131TCrs9392131221373302.39E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tCNA
671835518rs1857224AGrs1857224221373304.88E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGNA
817205577rs4921542TGrs4921542221373302.00E-08NA3.25[2.22-4.78] 93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGMTMR7
880227448rs1460163GArs1460163190815156.00E-08NANANA117 CJD cases; 3,083 controlsNOPOP(3200)ALL(3200)NOPOP(3200)ALL(3200)Creutzfeldt-Jakob diseaseHPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromers1460163-AResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.A
9114155811rs3737126TCrs3737126221373303.01E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTKIAA0368
11125241046rs12273350GArs12273350221373302.00E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tAPKNOX2
1271411561rs7132840TGrs7132840221373304.18E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
1271558448rs17226863GCrs17226863221373301.02E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGNA
1271566754rs7972188TCrs7972188221373301.83E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
1271566956rs1510937TCrs1510937221373302.28E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
1271577101rs1495377GCrs1495377221373302.00E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGNA
1279460072rs17273464GArs17273464221373305.31E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGSYT1
1588709057rs17830422TCrs17830422221373308.88E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNTRK3
1653648482rs9922369GArs9922369221373303.36E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGRPGRIP1L
1676935150rs1496961TGrs1496961221373303.50E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
1676949414rs1580765GArs1580765221373302.36E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
1676954287rs1874536GArs1874536221373302.61E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
1676955287rs4519342ATrs4519342221373303.39E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
1676978695rs12598288AGrs12598288221373305.55E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
171657073rs8074026TCrs8074026221373302.00E-10NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tCSERPINF2
1821515391rs1154238GArs1154238221373305.30E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tALAMA3
1853267742rs17061809CGrs17061809221373304.29E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tCTCF4
195743824rs3097891AGrs3097891221373304.22E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tACATSPERD
204677092rs6107516GArs6107516221373303.00E-18NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGPRNP
204680251rs1799990AGrs1799990190815152.00E-21NANANA117 CJD cases; 3,083 controlsNOPOP(3200)ALL(3200)NOPOP(3200)ALL(3200)Creutzfeldt-Jakob diseaseHPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromers1799990-AResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.A
204683295rs2065706TCrs2065706221373303.50E-09NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
204689474rs6052780GArs6052780221373308.03E-08NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tANA
204698626rs6116492GTrs6116492221373305.00E-07NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTNA
2220761899rs887023CTrs887023221373306.59E-06NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tTZNF74
X72743401rs17312304TGrs17312304221373303.59E-05NANANA93 European ancestry cases; 1,504 European ancestry controlsEuropean(1597)ALL(1597)EUR(1597)ALL(1597)Creutzfeldt-Jakob disease (variant)HPOID:0000708Behavioral abnormalityDOID:11949Creutzfeldt-Jakob syndromeD007562Creutzfeldt-Jakob SyndromeEFOID:0004226creutzfeldt jacob diseaseCreutzfeldt-Jakob syndromeNAResearch Support, Non-U.S. Gov'tGNA
Mapped by lexical matching(Total Items:2)
HP ID HP Name MP ID MP Name Annotation
HP:0002922Increased CSF proteinMP:0008469abnormal protein levelanomaly in the amount of any of the macromolecules consisting of long chains of amino acids in peptide linkage
HP:0002066Gait ataxiaMP:0001393ataxiainability to coordinate voluntary muscular movements
Mapped by homologous gene(Total Items:19)
HP ID HP Name MP ID MP Name Annotation
HP:0007076Extrapyramidal muscular rigidityMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
HP:0000737IrritabilityMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000739AnxietyMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000726DementiaMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0002066Gait ataxiaMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
HP:0000738HallucinationsMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0001289ConfusionMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
HP:0000716DepressionMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0002381AphasiaMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000605Supranuclear gaze palsyMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
HP:0002354Memory impairmentMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000505Visual impairmentMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0000741ApathyMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0005327Loss of facial expressionMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
HP:0001269HemiparesisMP:0020216decreased circulating complement protein levelless than normal levels of the serum proteins that act sequentially to allow for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes
HP:0001336MyoclonusMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0002922Increased CSF proteinMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0000751Personality changesMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000746DelusionsMP:0020187altered susceptibility to prion infectionaltered likelihood that an organism will develop ill effects from the small proteinaceous infectious particles which are resistant to inactivation by procedures that modify nucleic acids and which contain an abnormal isoform of a cellular protein that is
Disease ID 286
Disease creutzfeldt jakob disease
Case(Waiting for update.)